IN2014DN06965A - - Google Patents

Info

Publication number
IN2014DN06965A
IN2014DN06965A IN6965DEN2014A IN2014DN06965A IN 2014DN06965 A IN2014DN06965 A IN 2014DN06965A IN 6965DEN2014 A IN6965DEN2014 A IN 6965DEN2014A IN 2014DN06965 A IN2014DN06965 A IN 2014DN06965A
Authority
IN
India
Prior art keywords
relates
pregabalin
preparation
pharmaceutically acceptable
acrylic acid
Prior art date
Application number
Other languages
English (en)
Inventor
Varinder Kumar
Shavej Ahmad
Romi Barat Singh
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Priority to IN6965DEN2014 priority Critical patent/IN2014DN06965A/en
Publication of IN2014DN06965A publication Critical patent/IN2014DN06965A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN6965DEN2014 2012-01-30 2013-01-29 IN2014DN06965A (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN6965DEN2014 IN2014DN06965A (fr) 2012-01-30 2013-01-29

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN249DE2012 2012-01-30
PCT/IB2013/050762 WO2013114281A1 (fr) 2012-01-30 2013-01-29 Comprimés de prégabaline gastro-résistants
IN6965DEN2014 IN2014DN06965A (fr) 2012-01-30 2013-01-29

Publications (1)

Publication Number Publication Date
IN2014DN06965A true IN2014DN06965A (fr) 2015-04-10

Family

ID=48014112

Family Applications (1)

Application Number Title Priority Date Filing Date
IN6965DEN2014 IN2014DN06965A (fr) 2012-01-30 2013-01-29

Country Status (6)

Country Link
US (1) US20140378545A1 (fr)
EP (1) EP2809303A1 (fr)
AU (1) AU2013213859A1 (fr)
CA (1) CA2863371A1 (fr)
IN (1) IN2014DN06965A (fr)
WO (1) WO2013114281A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102221846B1 (ko) * 2014-04-07 2021-02-26 영진약품 주식회사 안정성이 개선된 프레가발린을 함유하는 약제학적 조성물 및 이의 제조방법
CN108159011A (zh) * 2018-03-16 2018-06-15 中国药科大学 一种双相控释的普瑞巴林胃滞留缓释片及其制备方法
ES2953059T3 (es) * 2019-07-03 2023-11-07 Alvogen Inc Comprimidos de liberación controlada de pregabalina, método de fabricación, y método de uso de los mismos
TWI733299B (zh) * 2020-01-07 2021-07-11 華宇藥品股份有限公司 普加巴林的持續-釋放配方
CN113577036B (zh) * 2021-05-31 2023-04-04 石药集团欧意药业有限公司 一种普瑞巴林胃漂浮缓释片及其制备方法
CN115721600B (zh) * 2022-11-10 2025-08-22 济川(上海)医学科技有限公司 一种胃滞留型普瑞巴林缓释组合物及其制备方法
CN120324357B (zh) * 2025-06-03 2025-10-24 上海国创医药股份有限公司 一种普瑞巴林缓释组合物及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6197819B1 (en) 1990-11-27 2001-03-06 Northwestern University Gamma amino butyric acid analogs and optical isomers
US5869029A (en) * 1996-06-21 1999-02-09 Hercules Incorporated Dispersible water-soluble or water-swellable polymers and process for making toothpastes containing them
EP0934061B3 (fr) 1996-07-24 2015-01-21 Warner-Lambert Company LLC Isobutylgaba et ses derives utilises pour le traitement de la douleur
NL2000281C2 (nl) 2005-11-02 2007-08-07 Pfizer Prod Inc Vaste farmaceutische samenstellingen die pregabaline bevatten.
EP2217217B1 (fr) 2007-11-23 2018-05-30 Lupin Limited Compositions pharmaceutiques de prégabaline à libération contrôlée
CA2765172A1 (fr) 2009-06-12 2010-12-16 Micro Labs Limited Nouvelles compositions pharmaceutiques contenant de la pregabaline
EP2389933A1 (fr) * 2010-05-25 2011-11-30 Sanovel Ilac Sanayi ve Ticaret A.S. Compositions comprenant de la prégabaline à libération contrôlée
EP2575798B1 (fr) 2010-06-01 2017-08-09 Rubicon Research Private Limited Formes galéniques gastrorétentives d'analogues de gaba
WO2013114283A1 (fr) * 2012-01-30 2013-08-08 Ranbaxy Laboratories Limited Comprimés gastro-résistants

Also Published As

Publication number Publication date
EP2809303A1 (fr) 2014-12-10
WO2013114281A1 (fr) 2013-08-08
AU2013213859A1 (en) 2014-08-21
US20140378545A1 (en) 2014-12-25
CA2863371A1 (fr) 2013-08-08

Similar Documents

Publication Publication Date Title
IN2014DN06966A (fr)
PH12015500561A1 (en) Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same
MX356210B (es) Formulaciones de polimero acrilico.
CL2013000028S1 (es) Conector
MX2013008850A (es) Composiciones y metodos para tratar enfermedades cardiovasculares.
PH12013500981A1 (en) Process for the preparation of a ppi-containing pharmaceutical product
CA2863371A1 (fr) Comprimes de pregabaline gastro-resistants
CA3276492A1 (en) Deuterated tetrahydrocurcumin and use thereof as a medicament
EP3102188A4 (fr) Nouveaux systèmes de désintégration de formes dosifiées pharmaceutiques
PH12018501072A1 (en) Modified release orally administered amino acid formulations
EA201692043A1 (ru) Лекарственная форма иммунодепрессанта
PH12014502856B1 (en) Solid pharmaceutical preparation containing levothyroxine
MX2016005477A (es) Formas de dosificacion disuasivas del abuso.
MX2016006087A (es) Formulaciones de desintegracion rapida y metodos de uso.
ES1093280Y (es) Conjunto de conector para aplicaciones de gas medicinal
PH12014501840A1 (en) Pharmaceutical formulation having improved stability
HK1244692A1 (zh) 治疗纤维化的方法
PH12014502325B1 (en) Sustained release tablet containing levodropropizine and method for preparing same
WO2016137266A3 (fr) Composition pharmaceutique contenant de l'épérisone et du pélubiprofène
EA201791089A1 (ru) Фармацевтические матричные составы, содержащие диметилфумарат
MX2015008171A (es) Formulacion que comprende agomelatina amorfa.
WO2013115736A3 (fr) Formulations pour comprimés bicouches de flurbiprofène et glucosamine
WO2014013090A3 (fr) Formulation comprenant du fingolimod amorphe
IN2014MU00215A (fr)
WO2014122671A3 (fr) Compositions orales solides de saxagliptine